Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000042

Chief Financial Officer returned 235 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Carter Robert Ross · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-11-20 Returned to the company : show line 1 in the form −235 $0.14 $32 31,759 D
Loading xslF345X05/wk-form4_1732231303.xml…